The TWEAK/Fn14 pathway is involved in the modulation of inflammation in several chronic AD, including multiple sclerosis, SLE, rheumatoid arthritis, or ulcerative colitis (17). The gene discussed is TNFRSF12A; the disease is systemic lupus erythematosus.